Fiera Capital (Europe)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$441K Hold
6,472
0.21% 23
2016
Q4
$462K Buy
6,472
+1,942
+43% +$144K 0.27% 24
2016
Q3
$359K Sell
4,530
-995
-18% -$80.8K 0.21% 23
2016
Q2
$459K Hold
5,525
0.36% 20
2016
Q1
$509K Buy
5,525
+1,906
+53% +$172K 0.5% 18
2015
Q4
$368K Buy
3,619
+813
+29% +$84.6K 0.44% 19
2015
Q3
$274K Sell
2,806
-402
-13% -$44.6K 0.36% 22
2015
Q2
$377K Sell
3,208
-1,101
-26% -$120K 0.34% 21
2015
Q1
$423K Sell
4,309
-149,158
-97% -$15.1M 0.38% 21
2014
Q4
$1.94K Buy
153,467
+149,447
+3,718% +$15.5M 1.43% 17
2014
Q3
$428K Buy
4,020
+1,110
+38% +$109K 0.31% 27
2014
Q2
$242K Buy
2,910
+408
+16% +$31.8K 0.19% 24
2014
Q1
$177K Sell
2,502
-501
-17% -$39.3K 0.13% 28
2013
Q4
$225K Buy
+3,003
New +$209K 0.13% 25

Other funds holding GILD

Fiera Capital (Europe)'s GILD Position: Q1 2017 in Review

Fiera Capital (Europe) held its Gilead Sciences (GILD) position steady in Q1 2017 at 6,472 shares worth $441K. The position accounts for 0.21% of the portfolio, ranked #23.

Fiera Capital (Europe) first reported a position in GILD in Q4 2013 and has held it in 14 quarters since. The position peaked at $509K in Q1 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Fiera Capital (Europe) held 6,472 shares of Gilead Sciences worth $441K as of Q1 2017.
  • Fiera Capital (Europe) left its Gilead Sciences share count unchanged in Q1 2017.
  • Gilead Sciences made up 0.21% of Fiera Capital (Europe)'s portfolio in Q1 2017, its #23 holding.
  • Fiera Capital (Europe) first reported a position in Gilead Sciences in Q4 2013 and has held it in 14 quarters since.
  • Fiera Capital (Europe)'s Gilead Sciences position peaked at $509K in Q1 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2017, filed 15 May 2017.